Combivent定氣快

Combivent

ipratropium bromide + salbutamol

Manufacturer:

Boehringer Ingelheim

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Per unit dose vial (UDV) inhalation soln Ipratropium Br anhydrous 0.5 mg, salbutamol (as sulphate) 2.5 mg
Indications/Uses
Reversible bronchospasm associated w/ obstructive airway diseases in patients who require more than a single bronchodilator.
Dosage/Direction for Use
Adult & childn >12 yr Acute attacks 1 UDV. If attack is not relieved, increase to 2 UDV. Maintenance 1 UDV tds-qds.
Contraindications
Hypertrophic obstructive cardiomyopathy, tachyarrhythmia. Hypersensitivity to atropine or its derivatives.
Special Precautions
Ocular complication, insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, phaeochromocytoma, risk of narrow-angle glaucoma, prostatic hypertrophy, bladder-neck obstruction, cystic fibrosis. Pregnancy & lactation.
Adverse Reactions
Dry mouth. Headache, dizziness, nervousness, tachycardia, tremor, palpitations, increased systolic BP, cough, nausea, dysphonia, urinary retention, asthenia.
Drug Interactions
Xanthine derivatives, β-adrenergic blockers, glucocorticosteroids, diuretics, digoxin, MAOIs, TCA, halogenated hydrocarbon anaesth.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03AL02 - salbutamol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Combivent soln for inhalation (UDV) 2.5 mL
Packing/Price
(unit dose vial) 2.5 mL x 20 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in